Literature DB >> 9162005

Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C.

Q Lin1, J Schwarz, C Bucana, E N Olson.   

Abstract

Members of the myocyte enhancer factor-2 (MEF2) family of MADS (MCM1, agamous, deficiens, serum response factor)-box transcription factors bind an A-T-rich DNA sequence associated with muscle-specific genes. The murine MEF2C gene is expressed in heart precursor cells before formation of the linear heart tube. In mice homozygous for a null mutation of MEF2C, the heart tube did not undergo looping morphogenesis, the future right ventricle did not form, and a subset of cardiac muscle genes was not expressed. The absence of the right ventricular region of the mutant heart correlated with down-regulation of the dHAND gene, which encodes a basic helix-loop-helix transcription factor required for cardiac morphogenesis. Thus, MEF2C is an essential regulator of cardiac myogenesis and right ventricular development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9162005      PMCID: PMC4437729          DOI: 10.1126/science.276.5317.1404

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  36 in total

1.  Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis.

Authors:  L Li; P Cserjesi; E N Olson
Journal:  Dev Biol       Date:  1995-11       Impact factor: 3.582

2.  Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies.

Authors:  W Zhang; R R Behringer; E N Olson
Journal:  Genes Dev       Date:  1995-06-01       Impact factor: 11.361

3.  MEF2B is a potent transactivator expressed in early myogenic lineages.

Authors:  J D Molkentin; A B Firulli; B L Black; J F Martin; C M Hustad; N Copeland; N Jenkins; G Lyons; E N Olson
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

4.  The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages.

Authors:  J F Martin; A Bradley; E N Olson
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

5.  A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila.

Authors:  G Ranganayakulu; B Zhao; A Dokidis; J D Molkentin; E N Olson; R A Schulz
Journal:  Dev Biol       Date:  1995-09       Impact factor: 3.582

6.  Distinct domains of myocyte enhancer binding factor-2A determining nuclear localization and cell type-specific transcriptional activity.

Authors:  Y T Yu
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

7.  Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5.

Authors:  I Lyons; L M Parsons; L Hartley; R Li; J E Andrews; L Robb; R P Harvey
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

8.  Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors.

Authors:  J F Martin; J J Schwarz; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants.

Authors:  T J Lints; L M Parsons; L Hartley; I Lyons; R P Harvey
Journal:  Development       Date:  1993-10       Impact factor: 6.868

10.  Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.

Authors:  D G Edmondson; G E Lyons; J F Martin; E N Olson
Journal:  Development       Date:  1994-05       Impact factor: 6.868

View more
  303 in total

Review 1.  The basic helix-loop-helix transcription factor, dHAND, is required for vascular development.

Authors:  H Yamagishi; E N Olson; D Srivastava
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Differential localization of HDAC4 orchestrates muscle differentiation.

Authors:  E A Miska; E Langley; D Wolf; C Karlsson; J Pines; T Kouzarides
Journal:  Nucleic Acids Res       Date:  2001-08-15       Impact factor: 16.971

Review 3.  Stem cells and the formation of the myocardium in the vertebrate embryo.

Authors:  Leonard M Eisenberg; Steven W Kubalak; Carol A Eisenberg
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2004-01

Review 4.  Building a heart: implications for congenital heart disease.

Authors:  Deepak Srivastava
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

Review 5.  Cardiogenesis: an embryological perspective.

Authors:  Ramón Muñoz-Chápuli; José M Pérez-Pomares
Journal:  J Cardiovasc Transl Res       Date:  2009-11-04       Impact factor: 4.132

6.  skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration.

Authors:  Chong Yon Park; Stephanie A Pierce; Morgan von Drehle; Kathryn N Ivey; Jayson A Morgan; Helen M Blau; Deepak Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-11       Impact factor: 11.205

7.  MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells.

Authors:  Peter J Gianakopoulos; Virja Mehta; Anastassia Voronova; Yi Cao; Zizhen Yao; Josée Coutu; Xiaonan Wang; Michelle S Waddington; Stephen J Tapscott; Ilona S Skerjanc
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

8.  mef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafish.

Authors:  Craig T Miller; Mary E Swartz; Patricia A Khuu; Macie B Walker; Johann K Eberhart; Charles B Kimmel
Journal:  Dev Biol       Date:  2007-05-24       Impact factor: 3.582

9.  HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo.

Authors:  Joshua P Anderson; Evdokia Dodou; Analeah B Heidt; Sarah J De Val; Eric J Jaehnig; Stephanie B Greene; Eric N Olson; Brian L Black
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Undermining the endothelium by ablation of MAPK-MEF2 signaling.

Authors:  Eric N Olson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.